» Articles » PMID: 35260822

Ubiquitin Ligase E3 HUWE1/MULE Targets Transferrin Receptor for Degradation and Suppresses Ferroptosis in Acute Liver Injury

Overview
Specialty Cell Biology
Date 2022 Mar 9
PMID 35260822
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic ischemia followed by reperfusion (I/R), a major clinical problem during liver surgical procedures, can induce liver injury with severe cell death including ferroptosis which is characterized by iron-dependent accumulation of lipid peroxidation. The HECT domain-containing ubiquitin E3 ligase HUWE1 (also known as MULE) was initially shown to promote apoptosis. However, our preliminary study demonstrates that high expression of HUWE1 in the liver donors corelates with less injury and better hepatic function after liver transplantation in patients. Thus, we investigate the role of HUWE1 in acute liver injury, and identify HUWE1 as a negative ferroptosis modulator through transferrin receptor 1(TfR1). Deficiency of Huwe1 in mice hepatocytes (HKO) exacerbated I/R and CCl-induced liver injury with more ferroptosis occurrence. Moreover, Suppression of Huwe1 remarkably enhances cellular sensitivity to ferroptosis in primary hepatocytes and mouse embryonic fibroblasts. Mechanistically, HUWE1 specifically targets TfR1 for ubiquitination and proteasomal degradation, thereby regulates iron metabolism. Importantly, chemical and genetic inhibition of TfR1 dramatically diminishes the ferroptotic cell death in Huwe1 KO cells and Huwe1 HKO mice. Therefore, HUWE1 is a potential protective factor to antagonize both aberrant iron accumulation and ferroptosis thereby mitigating acute liver injury. These findings may provide clinical implications for patients with the high-expression Huwe1 alleles.

Citing Articles

Mechanisms and preventive measures of ALDH2 in ischemia‑reperfusion injury: Ferroptosis as a novel target (Review).

Han L, Zhai W Mol Med Rep. 2025; 31(4).

PMID: 40017132 PMC: 11876945. DOI: 10.3892/mmr.2025.13470.


Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.


Mesenchymal stem cell-derived extracellular vesicles attenuate ferroptosis in aged hepatic ischemia/reperfusion injury by transferring miR-1275.

Gong Y, You Q, Yuan X, Zeng F, Zhang F, Xiao J Redox Biol. 2025; 81:103556.

PMID: 39986119 PMC: 11893313. DOI: 10.1016/j.redox.2025.103556.


PDE4B promotes ferroptosis in nucleus pulposus cells and is involved in intervertebral disc degeneration.

Xu W, Dhar R, Zheng D, Peng Q, Li Y, Mei S Sci Rep. 2025; 15(1):3984.

PMID: 39893206 PMC: 11787312. DOI: 10.1038/s41598-025-87639-8.


[Ferroptosis and liver diseases].

Li X, Tao L, Zhong M, Wu Q, Min J, Wang F Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025; 53(6):747-755.

PMID: 39757742 PMC: 11736349. DOI: 10.3724/zdxbyxb-2024-0566.


References
1.
Peralta C, Jimenez-Castro M, Gracia-Sancho J . Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013; 59(5):1094-106. DOI: 10.1016/j.jhep.2013.06.017. View

2.
Guicciardi M, Malhi H, Mott J, Gores G . Apoptosis and necrosis in the liver. Compr Physiol. 2013; 3(2):977-1010. PMC: 3867948. DOI: 10.1002/cphy.c120020. View

3.
Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View

4.
Conrad M, Friedmann Angeli J, Vandenabeele P, Stockwell B . Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2016; 15(5):348-66. PMC: 6531857. DOI: 10.1038/nrd.2015.6. View

5.
Fang X, Wang H, Han D, Xie E, Yang X, Wei J . Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019; 116(7):2672-2680. PMC: 6377499. DOI: 10.1073/pnas.1821022116. View